New award for clopidogrel bisulfate tablets with radha pharmaceuticals INC. Ordering period is april 15, 2023 through april 14, 204 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79723D0004
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Clopidogrel Bisulfate 75mg Tab (30s, 90s and 500s or 1000s) Pre-Solicitation · 36E79722R0039 · Posted Aug 18, 2022
- Last date to order 89% complete
- IDV ceiling
- $15,979,579.05
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded a single-award indefinite-delivery contract to Radha Pharmaceuticals Inc. for clopidogrel bisulfate tablets, with a ceiling of $15,979,579.05 and an award date of April 15, 2023. The contract carries no set-aside. The ordering period runs from April 15, 2023 through April 14, 2024, with four one-year options extending ultimate completion to April 14, 2027. Place of performance includes supply to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The originating solicitation, posted August 18, 2022 with a due date of September 14, 2022, sought reliable pharmaceutical sourcing under full and open competition to support the VA and DoD Pharmaceutical Prime Vendor programs. Radha Pharmaceuticals is a minority-owned manufacturer and distributor of generic pharmaceuticals. The contract employs firm-fixed pricing and is designed to provide an uninterrupted supply of clopidogrel bisulfate in various strengths and bottle configurations to federal medical facilities, with estimated requirements exceeding 200,000 units annually.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79723D0004?
36E79723D0004 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on April 15, 2023.
How much is contract 36E79723D0004 worth?
36E79723D0004's own ceiling is $15,979,579.
Who can order from contract 36E79723D0004?
36E79723D0004 is a single award indefinite delivery contract.
Was contract 36E79723D0004 competed?
The extent of competition for 36E79723D0004 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV